https://www.washingtonpost.com/health/2023/10/24/rsv-monoclonal-shortage-cdc-update/
0
0
36 words
0
Comments
The agency updated its guidance in response to limited supply of an antibody drug designed to protect infants from the potentially fatal respiratory disease.
You are the first to view
Create an account or login to join the discussion